Compound Profile: Caber 0.
Cabergoline is a synthetic ergot alkaloid derivative and selective dopamine D2 receptor agonist manufactured by Odin Pharmaceuticals. This compound demonstrates high specificity for dopamine receptors, particularly the D2 subtype, making it a valuable research tool for investigating dopaminergic pathways and prolactin regulation mechanisms. Each 0.5mg tablet provides consistent dosing for laboratory studies examining dopamine receptor pharmacology and endocrine system modulation. Researchers at Stroid UK Shop utilise this compound to study dopamine-mediated cellular signalling cascades and hormone regulation pathways in controlled experimental conditions.
Laboratory Applications
Research scientists investigate cabergoline for its profound effects on prolactin secretion suppression through hypothalamic dopamine receptor activation. Studies examine its long half-life properties, allowing for sustained dopaminergic stimulation in experimental models. This compound serves as a reference standard in post cycle therapy cabergoline research, particularly when studying hormonal recovery mechanisms following anabolic compound exposure. Comparative studies with other dopamine agonists help elucidate receptor selectivity patterns and downstream signalling pathways. Research applications extend to investigating dopamine’s role in mood regulation, motor function, and neuroendocrine control mechanisms in laboratory settings.
Product Specifications
| Active Compound | Cabergoline |
|---|---|
| Concentration | 0.5mg per tablet |
| Manufacturer | Odin Pharmaceuticals |
| Chemical Class | Ergot alkaloid derivative |
| CAS Number | 81409-90-7 |
| Molecular Formula | C₂₆H₃₇N₅O₂ |
| Storage | Room temperature, dry conditions |
Researchers also explore cabergoline alongside SARMs and peptides to understand multi-pathway hormonal interactions in comprehensive endocrine research protocols.
Research Compliance
This cabergoline preparation is intended strictly for in-vitro laboratory research and educational purposes only. Not approved for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must follow institutional safety protocols and maintain proper laboratory documentation when handling this compound.
